MIAMI - Pasithea Therapeutics Corp. (NASDAQ: KTTA), a micro-cap biotech firm with a market capitalization of $2.63 million focusing on developing treatments for central nervous system disorders and ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Alcohol is a chemical compound that typically refers to ethanol. This compound increases the production of a neurotransmitter called GABA, which immediately relaxes the central nervous system.

Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) will likely be posting its quarterly earnings results on Thursday, February 6th. Analysts expect Rapport Therapeutics to post earnings of ($0.62) ...

UVM’s Communication Sciences and Disorders program provides in-depth study of human communication and guided exploration of the fields of speech-language pathology and audiology that will prepare you ...